title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Geographic Atrophy Market to Boost Significantly, Assesses DelveInsight | Key Companies Active in the Domain - Novartis, Annexon, Apellis, Ionis, Astellas, Gyroscope, Genentech, Aviceda, Iveric Bio",20230628T210100,https://www.prnewswire.com/news-releases/geographic-atrophy-market-to-boost-significantly-assesses-delveinsight--key-companies-active-in-the-domain---novartis-annexon-apellis-ionis-astellas-gyroscope-genentech-aviceda-iveric-bio-301865699.html,IONS,0.051663,Neutral,0.002
"Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight",20240409T214100,https://www.prnewswire.com/news-releases/global-tissue-banking-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2030-assesses-delveinsight-302110459.html,IONS,0.022991,Neutral,0.033133
"Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight",20240124T220100,https://www.prnewswire.com/news-releases/drug-eluting-balloons-global-market-is-expected-to-expand-at-a-healthy-growth-rate-of-8-by-2028-predicts-delveinsight-302042856.html,IONS,0.025985,Neutral,0.033663
"Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight",20240115T220500,https://www.prnewswire.com/news-releases/heart-failure-treatment-drug-market-to-accelerate-immensely-by-2032-predicts-delveinsight-302034593.html,IONS,0.023441,Neutral,0.03228
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive ... - PR Newswire,20231201T183000,https://www.prnewswire.com/news-releases/neuromuscular-disease-therapeutics-market-size-to-grow-by-usd-65-13-billion-from-2022-2027-aquestive-therapeutics-inc-bausch-health-companies-inc-biogen-inc-and-more-among-the-major-companies-in-the-market--technavio-302002042.html,IONS,0.059636,Neutral,0.014995
Catalyst Pharmaceuticals  ( CPRX )  Rallies 43% YTD: Here's Why,20220722T160400,https://www.zacks.com/stock/news/1956606/catalyst-pharmaceuticals-cprx-rallies-43-ytd-heres-why,IONS,0.162437,Somewhat-Bullish,0.180008
Verve  ( VERV )  Up on Gene Editing Collaboration With Vertex,20220721T153400,https://www.zacks.com/stock/news/1955906/verve-verv-up-on-gene-editing-collaboration-with-vertex,IONS,0.229149,Somewhat-Bullish,0.200362
